New benchtop platform delivers in-solution interaction profiling from 10 μL samples, without surface immobilization.
Munich, Germany - July 1, 2026 - NanoTemper Technologies, a global leader in biophysical characterization solutions, today announced the launch of Monolith Omni, a new benchtop platform that combines affinity measurement, kinetic profiling, and stability analysis in a single, streamlined workflow. Designed for researchers working with challenging targets and limited material, Monolith Omni enables multi-parameter interaction characterization entirely in solution, using just 10 μL of sample.
A More Complete View of Biomolecular Interactions
Understanding how molecules interact is central to drug discovery, protein biochemistry, and fundamental biological research. While affinity measurements are an established starting point, kinetic and stability data are often critical for making confident decisions about candidates - yet obtaining them typically requires separate instruments, additional sample, and added workflow complexity.
Monolith Omni addresses this challenge. By integrating four complementary biophysical technologies - Spectral Shift, nanoTAK (nano Temperature Alteration Kinetics), nanoLISA (nano Laser Induced Stability Analysis), and TRIC (Temperature Related Intensity Change) - into a single instrument, researchers can now generate affinity constants, binding kinetics (kon/koff), thermodynamic parameters, and stability readouts from the same sample, in one workflow.
"Monolith Omni isn't just a product launch, it opens a new chapter for NanoTemper. It helps scientists move beyond data collection toward a deeper understanding of molecular interactions, with less friction, less sample, and a faster time to insight. For teams working on tough questions, that's a meaningful step forward." — Dr. Stefan Duhr, CEO, NanoTemper Technologies
What Monolith Omni Delivers
- Measurements are performed entirely in solution - no surface immobilization, no surface-related artifacts. Samples run in biologically relevant conditions, including detergent-solubilized membrane proteins and cell lysates.
- Target and modality range is exceptionally broad: membrane proteins, nucleic acids, small molecules, peptides, PROTACs, molecular glues, and degrader-induced ternary complexes are all accessible without workflow changes.
- nanoTAK delivers binding kinetics free from the mass transport limitations that constrain surface-based methods. nanoLISA assesses protein unfolding and early aggregation at nanomolar concentrations in seconds - providing orthogonal hit confirmation without added complexity.
- At just 10 μL per capillary, Monolith Omni is built for experiments where material is scarce, difficult to produce, or simply too valuable to waste.
- Productive from day one: Installation and training can be completed in a single day. Intuitive software guides users through setup and analysis, with automated, publication-quality outputs.
Monolith Omni is available now.
For more information, visit nanotempertech.com/monolith-omni or contact a NanoTemper specialist at nanotempertech.com/contact.
About NanoTemper Technologies
NanoTemper Technologies delivers biophysical characterization solutions that simplify complex science, helping researchers and biopharma teams move from data to decision faster. Co-created with scientists, NanoTemper's products help answer more questions, optimize existing workflows, and proceed with higher confidence in results. Partnering across industry and academia, NanoTemper supports innovation from discovery through manufacturing, advancing towards a future where every disease is treatable.
For more information, visit nanotempertech.com.
Media Contact
Stefan Duhr, CEO, NanoTemper Technologies | stefan.duhr@nanotempertech.com
© 2026 NanoTemper Technologies GmbH and its subsidiaries. All rights reserved. NanoTemper®, Monolith™ are trademarks or registered trademarks of NanoTemper Technologies GmbH.